www.protgeninc.com
Innovation Type:
Therapeutics
Cancer Type:
Heme
Funding Stage:
Seed
Fund:
Compass Rose
Novel platform generating progenitor T (Pro T) cells to restore weakened immune systems for better patient survival and outcomes to cancer treatments.